The crude extract of Aspergillus fumigatus isolate AF3-093A, an endophyte of the brown alga Fucus vesiculosus, showed significant antimicrobial activity in initial bioactivity screens. Bioassay-guided fractionation of the extract led to the isolation of flavipin, chaetoglobosin A and chaetoglobosin B, all of which inhibited the growth of Staphylococcus aureus, methicillin-resistant S. aureus and Mycobacterium tuberculosis H37Ra. The antimycobacterial activity of these compounds has not been previously reported.
Endophytic fungi are increasingly being recognized as important sources of bioactive natural products [1] [2] [3] . However, most of the research conducted thus far has involved endophytes from terrestrial plants, with relatively few studies focusing on marine algal endophytes [1, 4] . We recently compiled a library of fungal endophytes that were isolated from marine macroalgae collected in the Shetland Islands, UK [5] . Extracts of the fungi were screened for antimicrobial activity [5] and the extract of an Aspergillus fumigatus isolate (AF3-093A, GenBank accession number JX9670930) obtained from Fucus vesiculosus significantly inhibited the growth of Staphylococcus aureus and was therefore selected for further investigation.
The EtOAc extract obtained from a two-week bench-scale (5L) fermentation of AF3-093A was fractionated using a modified Kupchan liquid-liquid partition, with the CH 2 Cl 2 fraction showing significant antimicrobial activity towards S. aureus. Size exclusion chromatography of the CH 2 Cl 2 fraction over Sephadex LH-20 followed by high performance liquid chromatography (HPLC) of the subsequent bioactive fractions led to the isolation of flavipin (1), chaetoglobosin A (2) and chaetoglobosin B (3) as the antimicrobial constituents of the extract (Figure 1 ). The compounds were identified by mass spectrometry, NMR spectroscopy (1D and 2D) and polarimetry, and the data obtained were consistent with literature values [6] [7] [8] . All three compounds exhibited moderate to weak inhibitory activity towards S. aureus, however, further testing revealed that they possessed significantly greater bioactivity towards methicillin-resistant S. aureus and Mycobacterium tuberculosis H37Ra (Table 1) .
Flavipin and the chaetoglobosins A and B have been reported from several taxa of fungi [9] [10] [11] [12] [13] that include endophytic species [14] [15] [16] [17] , although they have not been isolated previously from A. fumigatus. Flavipin, originally isolated from A. flavipes [9] , has been reported to display broad-scale antimicrobial activity [10, 15, 18] , whilst the chaetoglobosins A and B, originally isolated from Chaetomium globosum [11] , are known for their toxicity to human cancer cell lines [7, 13, 16, 19] . Although chaetoglobosin B has been reported to show weak activity against S. aureus [17] , anti-staphylococcal activity has not been previously reported for either flavipin or chaetoglobosin A. Similarly, this is the first report of the antimycobacterial activity of the three compounds. 
Experimental

Fermentation and extraction of Aspergillus fumigatus (AF3-093A):
The isolation and identification of AF3-093A (accession number JX967093) has been previously described [5] . The fungus was fermented in 2% malt extract broth at room temperature under ambient light for 2 weeks (5L: 50 × 100 mL batches in 250 mL Erlenmeyer flasks covered with aluminum foil) with shaking (150 rpm). The fungal mycelia and spent culture broth were separated by suction filtration, and the culture broth was extracted with EtOAc (5 × 1 L batches using 3 × 300 mL EtOAc per batch). The resulting organic fractions were combined and concentrated in vacuo to give a crude extract (517 mg). using microbroth dilution and microplate resazurin assays respectively, as previously described [5, 20] . Antibacterial activity against methicillin-resistant S. aureus (ATCC 33593) was determined using a procedure identical to that used for the drug susceptible S. aureus strain [5] . Positive controls for the antibacterial assays consisted of a triplicate twofold serial dilution of gentamicin for S. aureus (2.62 -0.66 μM), ciprofloxacin for MRSA (0.60 -0.15 μM) and rifampin for M. tuberculosis (0.0061 -0.0015 μM).
Biological assays:
Bioassay guided fractionation:
A portion of the crude extract (504 mg) was dissolved in 9:1 MeOH:H 2 O (50 mL) and extracted with hexanes (3 × 20 mL) before being diluted with H 2 O (25 mL) and extracted with CH 2 Cl 2 (3 × 20 mL). The aqueous fraction was then concentrated in vacuo, dissolved in H 2 O (50 mL) and extracted with EtOAc (3 × 20 mL) and n-BuOH (3 × 20 mL). The resulting 5 fractions were concentrated in vacuo and only the CH 2 Cl 2 fraction (213 mg) showed significant antibiotic activity. The CH 2 Cl 2 fraction (207 mg) was further separated by size exclusion chromatography over Sephadex LH20 in MeOH to give 6 fractions that exhibited distinct TLC profiles. Fraction 3 (69 mg) showed significant antibiotic activity and was further purified by normal phase HPLC (31 mg, 65:35 hexanes/EtOAc) to give 1 (13 mg) and a fraction that contained 2 and 3 (19 mg) . Reversed phase HPLC of the mixed fraction (12 mg, 3:1 MeOH: H 2 O) gave 2 (2 mg) and 3 (2 mg).
